Real-time assessment of circulating tumor cells refines the indication for HER2-targeted therapy in metastatic gastric cancer
Abstract HER2-targeted therapies have improved outcomes in metastatic gastric cancer (mGC), yet assessment of HER2 status in tumor tissues remains limited by heterogeneity and temporal changes. This study aimed to evaluate real-time HER2 expression on circulating tumor cells (CTCs) using the On-chip...
Saved in:
| Main Authors: | Yasuaki Kimura, Koichi Suzuki, Sawako Tamaki, Iku Abe, Yuhei Endo, Kosuke Ichida, Yuta Muto, Fumiaki Watanabe, Masaaki Saito, Kazuo Takeda, Toshiki Rikiyama |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-06913-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer.
by: Fumiaki Watanabe, et al.
Published: (2019-01-01) -
Temporary loss of consciousness during cetuximab treatment of a patient with metastatic colon cancer: a case report
by: Taro Fukui, et al.
Published: (2019-10-01) -
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
by: Lucía Gandullo‐Sánchez, et al.
Published: (2020-04-01) -
Fully automatic HER2 tissue segmentation for interpretable HER2 scoring
by: Mathias Öttl, et al.
Published: (2025-04-01) -
Long-term survival after multidisciplinary treatments for HER2-positive advanced gastric cancer with multiple liver and lung metastases
by: Satoshi Yoshioka, et al.
Published: (2023-08-01)